TABLE OF CONTENTS
1 INTRODUCTION 10
1.1 OBJECTIVES OF THE STUDY 10
1.2 MARKET DEFINITION 10
1.3 OVERVIEW 10
1.4 LIMITATIONS 11
1.5 MARKETS COVERED 12
2 MARKET SEGMENTATION 16
2.1 MARKETS COVERED 16
2.2 GEOGRAPHICAL SCOPE 17
2.3 YEARS CONSIDERED FOR THE STUDY 18
2.4 CURRENCY AND PRICING 18
2.5 DBMR TRIPOD DATA VALIDATION MODEL 19
2.6 MULTIVARIATE MODELING 22
2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 23
2.8 DBMR MARKET POSITION GRID 24
2.9 MARKET APPLICATION COVERAGE GRID 25
2.10 DBMR VENDOR SHARE ANALYSIS 26
2.11 SECONDARY SOURCES 27
2.12 ASSUMPTIONS 28
3 EXECUTIVE SUMMARY 29
4 PREMIUM INSIGHTS 31
4.1 PESTLE ANALYSIS 32
4.1.1 POLITICAL FACTORS: 32
4.1.2 ECONOMIC FACTORS: 33
4.1.3 SOCIAL FACTORS: 33
4.1.4 TECHNOLOGICAL FACTORS: 33
4.1.5 LEGAL FACTORS: 34
4.1.6 ENVIRONMENTAL FACTORS: 35
4.2 PORTERS FIVE FORCES 36
4.3 VENDOR SELECTION CRITERIA 38
5 DYNAMICS OF RAW MATERIAL PREFERENCES 40
5.1 PLASTIC AND POLYMERS: 40
5.1.1 HDPE (HIGH-DENSITY POLYETHYLENE): 40
5.1.2 LDPE (LOW-DENSITY POLYETHYLENE): 40
5.1.3 PET (POLYETHYLENE TEREPHTHALATE): 40
5.1.4 PVC (POLYVINYL CHLORIDE): 40
5.1.5 PP (POLYPROPYLENE): 40
5.1.6 COC (CYCLIC OLEFIN COPOLYMER): 41
5.2 GLASS: 41
5.2.1 TYPE IV-NP (GENERAL PURPOSE SODA LIME GLASS): 41
5.2.2 TYPE I (BOROSILICATE GLASS): 41
5.2.3 TYPE III (REGULAR SODA-LIME GLASS): 41
5.2.4 TREATED SODA LIME GLASS: 42
5.3 METAL: 42
5.3.1 TIN: 42
5.3.2 IRON: 42
5.3.3 ALUMINIUM: 42
5.3.4 LEAD: 42
5.4 PAPER AND BOARD: 43
5.4.1 SOLID BOARD: 43
5.4.2 CHIPBOARD: 43
5.4.3 CARDBOARD: 43
5.4.4 FIBER BOARD: 43
5.5 RUBBER: 44
5.5.1 NATURAL RUBBER IN CONTRACT PHARMACEUTICAL PACKAGING: 44
5.5.2 NEOPRENE RUBBER IN CONTRACT PHARMACEUTICAL PACKAGING: 44
5.5.3 BUTYL RUBBER IN CONTRACT PHARMACEUTICAL PACKAGING: 44
6 PARTNERSHIP DETAILS 45
7 TECHNOLOGICAL ADVANCEMENTS 47
8 MARKET OVERVIEW 49
8.1 DRIVERS 51
8.1.1 STRONG SPENDING TOWARDS PHARMA INDUSTRY 51
8.1.2 IMPACT OF COMPLEX DRUG FORMULATIONS AND SPECIALIZED PACKAGING NEEDS 52
8.1.3 IMPACT OF REGULATORY COMPLIANCE AND QUALITY ASSURANCE DEMANDS 53
8.2 RESTRAINTS 54
8.2.1 AVAILABILITY OF CHOICE OF IN-HOUSE PACKAGING FROM MANUFACTURERS 54
8.2.2 SUSTAINABILITY CONCERNS DUE TO USAGE OF PLASTICS IN PACKAGING MATERIALS 54
8.3 OPPORTUNITIES 55
8.3.1 TECHNOLOGICAL ADVANCEMENTS IN PACKAGING MACHINERY AND MATERIALS 55
8.3.2 RISING NEED FOR BIOPHARMACEUTICAL COLD CHAIN PACKAGING 56
8.4 CHALLENGE 57
8.4.1 DIVERSE CONCERNS RELATED TO OPERATIONAL HURDLES 57
9 MIDDLE EAST & AFRICA CONTRACT PHARMACEUTICAL PACKAGING MARKET: BY REGION 58
9.1 MIDDLE EAST & AFRICA 58
10 MIDDLE EAST & AFRICA CONTRACT PHARMACEUTICAL PACKAGING MARKET: COMPANY LANDSCAPE 59
10.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA 59
11 SWOT ANALYSIS 60
12 COMPANY PROFILE 61
12.1 ABBVIE INC. 61
12.1.1 COMPANY SNAPSHOT 61
12.1.2 REVENUE ANALYSIS 61
12.1.3 COMPANY SHARE ANALYSIS 62
12.1.4 SERVICE PORTFOLIO 62
12.1.5 RECENT DEVELOPMENTS 62
12.2 PCI PHARMA SERVICES 63
12.2.1 COMPANY SNAPSHOT 63
12.2.2 COMPANY SHARE ANALYSIS 63
12.2.3 SERVICE PORTFOLIO 64
12.2.4 RECENT DEVELOPMENTS 64
12.3 NELIPAK CORPORATION 65
12.3.1 COMPANY SNAPSHOT 65
12.3.2 COMPANY SHARE ANALYSIS 65
12.3.3 PRODUCT PORTFOLIO 65
12.3.4 RECENT DEVELOPMENTS 66
12.4 SHARP SERVICES, LLC 67
12.4.1 COMPANY SNAPSHOT 67
12.4.2 COMPANY SHARE ANALYSIS 67
12.4.3 PRODUCT PORTFOLIO 68
12.4.4 RECENT DEVELOPMENTS 69
12.5 APHENA PHARMA SOLUTIONS 70
12.5.1 COMPANY SNAPSHOT 70
12.5.2 COMPANY SHARE ANALYSIS 70
12.5.3 SERVICE PORTFOLIO 71
12.5.4 RECENT DEVELOPMENT 71
12.6 AMERIPAC 72
12.6.1 COMPANY SNAPSHOT 72
12.6.2 PRODUCT PORTFOLIO 72
12.6.3 RECENT DEVELOPMENT 72
12.7 ASSEMBLIES UNLIMITED, INC. 73
12.7.1 COMPANY SNAPSHOT 73
12.7.2 SERVICE PORTFOLIO 73
12.7.3 RECENT DEVELOPMENT 74
12.8 JONES HEALTHCARE GROUP 75
12.8.1 COMPANY SNAPSHOT 75
12.8.2 PRODUCT PORTFOLIO 75
12.8.3 RECENT DEVELOPMENT 76
12.9 REED-LANE 77
12.9.1 SNAPSHOT 77
12.9.2 PRODUCT PORTFOLIO 77
12.9.3 RECENT DEVELOPMENT 78
12.10 ROPACK INC. 79
12.10.1 COMPANY SNAPSHOT 79
12.10.2 PRODUCT PORTFOLIO 79
12.10.3 RECENT DEVELOPMENT 79
12.11 SEPHA 80
12.11.1 COMPANY SNAPSHOT 80
12.11.2 PRODUCT PORTFOLIO 80
12.11.3 RECENT DEVELOPMENTS 81
12.12 SILGANUNICEP 82
12.12.1 COMPANY SNAPSHOT 82
12.12.2 SERVICE PORTFOLIO 82
12.12.3 RECENT DEVELOPMENTS 83
12.13 STERNMAID GMBH & CO. KG 84
12.13.1 COMPANY SNAPSHOT 84
12.13.2 SERVICE PORTFOLIO 84
12.13.3 RECENT DEVELOPMENTS 84
12.14 TJOAPACK 85
12.14.1 COMPANY SNAPSHOT 85
12.14.2 SERVICE PORTFOLIO 85
12.14.3 RECENT DEVELOPMENT 86
12.15 TRIPAK PHARMACEUTICALS 87
12.15.1 COMPANY SNAPSHOT 87
12.15.2 SERVICE PORTFOLIO 87
12.15.3 RECENT DEVELOPMENTS 87
12.16 WASDELL PACKAGING GROUP 88
12.16.1 COMPANY SNAPSHOT 88
12.16.2 PRODUCT PORTFOLIO 88
12.16.3 RECENT DEVELOPMENT 88
13 QUESTIONNAIRE 89
14 RELATED REPORTS 92

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.